UPTON, NY—A cube, an octahedron, a prism—these are among the polyhedral structures, or frames, made of DNA that scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory have designed to connect nanoparticles into a variety of …
UPTON, NY — Participants in Pianofest, a summer workshop held in the Hamptons, will be showcased in two recitals at the U.S. Department of Energy's Brookhaven National Laboratory on Wednesday, July 6, and Wednesday, August 3, at noon in Berkner Hall. …
The following news release is based on a release issued on June 14 by the Data Science Institute at Columbia University. UPTON, NY—Chemically the same, graphite and diamonds are as physically distinct as two minerals can be, one opaque and soft, the other …
The following news release on funding for projects to help commercialize promising energy technologies was issued today by the U.S. Department of Energy. The announcement includes two Brookhaven National Laboratory projects on the development of electrodes …
Munich, Germany, June 22, 2016 / B3C newswire / -- Morphochem, a private clinical-stage pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) Application for the company’s …
Final results from the Phase I study with YELIVA™ (ABC294640) in patients with advanced solid tumors confirmed that the study, conducted at the Medical University of South Carolina (MUSC), successfully met its primary and secondary endpoints, demonstrating …
The first patients have been dosed in the randomized, double-blind, placebo-controlled Phase II study with BEKINDA™ 12 mg for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D) in 120 subjects in 12 clinical sites in the U.S. IBS is one …
Groningen, The Netherland, June 21, 2016 / B3C newswire / -- Polyganics, a privately held medical technology company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, announced …
Montréal, Québec, Canada, June 20, 2016 / B3C newswire / -- TVM Life Science Ventures VII closed the fund’s eleventh investment, establishing Mediti Pharma Inc., a company based in Montréal, Québec. Mediti Pharma Inc. is developing a compound, MP-101, …
Mainz, Germany, June 16, 2016 / B3C newswire / -- BioNTech Diagnostics GmbH, a subsidiary of BioNTech AG, announces the publication of new study data that prove the significant advantages of the in vitro diagnostic test kit MammaTyper® (CE / IVD marked) …
Vienna, Austria, June 16, 2016 / B3C newswire / -- Hookipa Biotech AG, a company pioneering a new class of immunotherapies and vaccines, today announces the appointment of Mr. Jörn Aldag as CEO. Mr. Aldag brings significant leadership experience and sector …
Leuven, Belgium, June 16, 2016 / B3C newswire / -- TROD Medical NV, the medical device company developing tools for focal ablation announces completion of enrollment in its clinical study at two world-renown cancer research institutions, University College …
New expandable benchtop workstation with unique single-use bioreactor design offers a simple approach to process development for fermentation and cell culture Goettingen, Germany, Cambridge, UK June 15, 2016 / B3C newswire / -- Sartorius Stedim Biotech ( …
Uppsala, Sweden, June 14, 2016 / B3C newswire / -- Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, is pleased to announce that they have achieved ISO 14001:2004 certification. This …
Cellca’s Cell Line and Upstream Process Development Services Now Integrated Glasgow, UK, June 14, 2016 / B3C newswire / -- Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry announced that its subsidiary …
First risk-mitigating virus-retentive filter for cell culture media Goettingen, Germany, Aubagne, France, June 13, 2016 / B3C newswire / -- Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has launched …
The PRospective study Of MammaPrint in breast cancer patients with an Intermediate recurrence Score (PROMIS) included 840 women at 58 US institutions. 45% of patients with an intermediate/indeterminate Recurrence Score from a 21-gene assay OncotypeDx ( …
Uppsala, Sweden, June 7, 2016 / B3C newswire / -- Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, is pleased to announce the launch of a new range of On-line SPE Cartridges, an …
Billingham, U.K., June 6, 2016 / B3C newswire / -- FUJIFILM Diosynth Biotechnologies, a leading global biologics Contract Development and Manufacturing Organization (CDMO), has announced that it is in the process of establishing a long-term collaboration …
IMAB362 nearly doubles survival in patients with the highest levels of Claudin18.2 target Mainz, Germany, June 5, 2016 / B3C newswire / -- Ganymed Pharmaceuticals AG, a biopharmaceutical company developing highly targeted immunotherapies against cancer, …
02 days 11:08:28
